C.R.A.P. =SPECIAL EDITION= One Big Bill and MEDICARE=8/4/2025
C.R.A.P. Special Edition – "One Big Bill" and MEDICARE
- In four recent Special Editions, we’ve looked at the impact of H.R. 1 ( "One Big Beautiful Bill") on
- US healthcare in general. Click here for that issue.
- Medicaid in particular. Click here for that issue.
- The ACA Click here for that issue
- Rural Health and click here for that issue.
- This week we take a deeper look at the impact of HR 1 on MEDICARE specifically
- For reference – here is our AI Notebook where you can ‘chat’ and ask questions about the Bill
- If you want more info on how to use above – drop me a note E-Mail Us or see this video.
-
New! – Play the great new game everyone’s talking about (well, I am at least) "Catch CRAP" Developed by HAPCO’s crack development staff using Claude Code (AI coding).
Summary Graphic
HR1 ("OBBB") Impact on Medicare (Source: CRAP Analysis). See below or click here
Produced 8/4/2025:
- For a copy of the Bill itself (all 870 pages of it) – click here.
H.R. 1’s ("OBBB") Impact on MEDICARE
- H.R. 1 has provisions affecting Medicare. Below, significant provisions are grouped into four categories.
A. Drug pricing and benefits
-
HR 1 expands the orphan drug exclusion from price negotiation, offering a broader definition for these specialized medications. "Orphan drugs" are drugs for rare diseases affecting a small number of people in the USA.
-
More on this Expanded Orphan Drug Exclusion below. The general idea is that CMS will not negotiate pricing for a broader range of drugs – specifically those addressing multiple rare diseases.
The bill broadens the definition of an orphan drug that is excluded from the Medicare Drug Price Negotiation Program. HR1 changes the criterion from being designated for "only 1 rare disease or condition" to "one or more rare diseases or conditions".
The term "rare disease or condition" is explicitly defined by reference to Federal legislation.
A new provision clarifies the treatment of former orphan drugs: if a drug or biological product was designated as an orphan drug at the time of its approval or licensure, its exclusion from negotiation will apply as if its reference date for approval or licensure was adjusted. These changes related to orphan drugs will be effective for initial price applicability years beginning on or after January 1, 2028
B. Provider payments and operations,
-
HR1 institutes a temporary 2.5 percent payment increase for physicians from 2026 to 2027
-
Imposes a moratorium on new long-term care staffing standards until 2034 (in other words: whereas the Biden Administration mandated a higher level of staffing for Nursing Homes, HR 1 delays the rollout of those standards).
C. Eligibility and enrollment standards
-
HR 1 limits Medicare eligibility primarily to U.S. citizens, lawful permanent residents, and specific immigrant statuses, requiring a review of current enrollees.
More on this topic of Limited Medicare Coverage for Certain Individuals:
The bill adds a new section (1899C) to Title XVIII of the Social Security Act that limits Medicare entitlement or enrollment to individuals who are:
Citizens or nationals of the UnitedStates
Aliens lawfully admitted for permanent residence
Aliens granted Cuban and Haitian entrant status
Individuals lawfully residing in the United States under a Compact of Free Association.In addition there is a requirement for the Application and Review for Current Enrollees: For individuals already entitled to or enrolled for Medicare benefits as of the enactment date, these new eligibility requirements (above) will apply starting 18 months after enactment. The Commissioner of Social Security is required to review current enrollees within one year to identify those who do not meet these new criteria and notify them of impending termination of benefits.
The way I read this – is that the Social Security Administration will check on all Medicare beneficiaries to ensure they fit in one of the 4 categories above.
D. Rural health initiatives
- HR 1 establishes a significant Rural Health Transformation Program, allocating billions of dollars to states for improving healthcare access, outcomes, and infrastructure in rural communities through various initiatives (see our analysis of HR1’s impact on Rural Health here).
- Although the "RHTP" impacts rural communities in general, the benefit to the Medicare program itself can be significant, given the higher care needs of seniors, and the dependency of rural hospitals on Medicare funding.
References
Here is a list of key references and sources underlying the detailed analysis of H.R. 1 impacts on Medicare and the other topics discussed, including those cited or extractable from the attached PDF (H.R. 1) and relevant external resources:
1. Primary Source: H.R. 1 Bill Text (119th Congress)
-
This is the authoritative source for all legislative provisions in detail, including Medicare-specific sections. It contains detailed subtitles, chapters, and sections relevant to Medicare reforms.
-
Relevant Titles/Subtitles among many are:
-
Title VII—Finance, Subtitle B—Health, Chapter 2—Medicare (e.g., Sections 71201–71203, Medicare-specific provisions)
-
Medicare drug pricing and plan reforms in Subtitle C—Health Tax
-
Rural Health provisions (Title VII, Subtitle D) impacting Medicare rural adjustments.
-
-
How to access: The PDF file “BILLS-119hr1enr.pdf” (attached) contains the full text. Official versions are also available on Congress.gov.
2. Medicare Program Specific Law and Regulations
-
Social Security Act, Title XVIII (42 U.S.C. § 1395 et seq.) — Fundamental federal statute governing Medicare.
-
CMS Regulations and Manuals — Provide implementation guidance for provider payments, enrollment rules, fraud prevention, and Part D plan management.
3. Medicare Drug Pricing and Negotiation Background
-
Inflation Reduction Act of 2022 (IRA) — Established initial Medicare drug price negotiation framework. H.R. 1 proposes modifications here.
-
Medicare Part D Regulations — Governing benefit design, costs, and drug coverage limits.
4. Medicare Advantage Program Rules
-
CMS rules implementing star ratings, quality bonus payments, and supplemental benefit criteria. H.R. 1 proposes reforms for enhanced oversight and quality measurement changes.
5. Rural Health and Telehealth References
-
CMS policy documents on telehealth expansions during COVID-19 and temporary waivers now contemplated for permanent adoption in rural Medicare.
-
Statutes authorizing critical access hospital payments and rural adjustments.
6. Program Integrity and Fraud Enforcement Law
-
False Claims Act (31 U.S.C. §§ 3729–3733) — Provides the legal basis for fraud penalties.
-
CMS Provider Enrollment Processes — Background for enhanced screening rules proposed in H.R. 1.
-
Office of Inspector General (OIG) Medicare audit and fraud detection programs.
7. Congressional Research Service (CRS)
-
Provides detailed legislative summaries and analyses after bills pass or near passage, including reports on Medicare provisions.
8. Non-Governmental Policy Analysis Sources
-
Kaiser Family Foundation (KFF): Updates on Medicare policy changes and drug pricing.
-
Medicare Payment Advisory Commission (MedPAC): Advises Congress on Medicare payment reforms and provider rules.
-
National Academy for State Health Policy (NASHP): Insight into rural and program integrity challenges in Medicare.
9. Additional Legislative Context
-
Related acts referenced or amended by H.R. 1 that affect Medicare include:
-
Social Security Act amendments
-
Federal Food, Agriculture, Conservation, and Trade Acts (for rural health links)
-
Internal Revenue Code (for tax provisions linked to Medicare and HSAs)
-
How to Use These References:
-
PDF navigation: Use search terms like “Medicare,” “Fee Schedule,” “Part D,” “Telehealth,” “fraud,” and section numbers (e.g., “71201”) within the bill PDF.
-
External websites: Visit www.congress.gov for bill versions and summaries, www.kff.org and www.medpac.gov for analyses, and www.cms.gov for policy updates.
-
Use official U.S. Code access (e.g., via govinfo.gov) for statutory baseline comparisons.
Note:
For authoritative program context/definitions, see corresponding sections in the U.S. Code or the cited bill. For the current law baseline, the above U.S. Code sections and government program summaries represent the appropriate comparison points.
See back issues of Daily C.R.A.P. on our website right here in the archive.
As of today, C.R.A.P. now has 145 subscribers
Want to drop us a line? E-Mail Us
Click here for ALL articles added to C.R.A.P. in the past 24 hours